Editor’s note: This is a developing news story. Please check back soon for updates.
The Prima photovoltaic retinal stimulation microchip, a brain-computer interface device designed to restore vision in patients with geographic atrophy, has launched commercially across 30 European countries.
According to a press release from Science Corp., the implant is the first brain-computer interface (BCI) device to receive CE marking for vision restoration in dry age-related macular degeneration, with the first commercial implant procedure expected to take place in Germany. The launch is supported by